Rare but serious Pancreatitis Severe allergic reaction Worsening of diabetic retinopathy in some patients with type 2 diabetes (semaglutide specifically) Bowel obstruction in patients with prior gastrointestinal surgery We review your history for the conditions that raise these risks before prescribing, and we tell you which symptoms mean stop the medication and call us
Instead, you will be provided with compounded semaglutide+B12 in vial form
Victoza was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. But we dont have to look at previous generations of GLP-1s so see the risk that unknown side effects have
Weeks 12: 2 mg once weekly Weeks 34: 4 mg once weekly Weeks 58: 8 mg once weekly Week 9+: 12 mg once weekly Efficacy and safety: The reason for the slow and gradual dosing protocol The Phase 2 clinical trial of retatrutide demonstrated that participants receiving the highest dose (12 mg) achieved up to 24% weight reduction after 48 weeks
Risks to be aware of with peptides While many peptides may be considered generally safe when used under medical supervision, there are risks attached to them that users should educate themselves on
44 GIP and effects on bone metabolism In agreement with direct receptor effects on osteoblasts and osteoclasts, GIP exerts both an anabolic and anti-catabolic action in bone